Psychosocial risk factors of cardiovascular diseases and possibilities of their intervention

1. Perk J, De Backer G, Gohlke H et al. European Guide­lines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635–1701.

2. Mookadam F, Arthur HM. Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview. Arch Intern Med 2004; 164: 1514–1518.

3. Malzberg B. Mortality among patients with involutional melancholia. Am J Psychiatry 1937; 93: 1231–1238.

4. Frasure-Smith N, Lespérance F. Depression and cardiac risk: present status and future directions. Heart 2010; 96: 173–176.

5. Barefoot JC, Helms MJ, Mark DB et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613–617.

6. Grace SL, Abbey SE, Kapral MK et al. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005; 96: 1179–1185.

7. Ait-Oufella H, Taleb S, Mallat Z et al. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 31: 969–979.

8. Dowlati Y, Herrmann N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–457.

9. Maletic V, Robinson M, Oakes T et al. Neurobiology of depression: an integrated view of key findings. Int J Clin Pract 2007; 61: 2030–2040.

10. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 2004; 55: 1–9.

11. Licht CM, de Geus EJ, Zitman FG et al. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 2008; 65: 1358–1367.

12. Baune BT, Stuart M, Gilmour A et al. Moderators of the relationship between depression and cardiovascular disorders: a systematic review. Gen Hosp Psychiatry 2012; 34: 478–492.

13. Glassman AH, O‘Connor CM, Califf RM et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701–709.

14. Joynt KE, O‘Connor CM. Lessons from SADHART, ENRICHD, and other trials. Psychosom Med 2005; 67 (Suppl 1): S63–S66.

15. Berkman LF, Blumenthal J, Burg M et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106–3116.

16. Dowlati Y, Herrmann N, Swardfager WL et al. Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Can J Psychiatry 2010; 55: 91–99.

17. Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of depression and anxiety. Int J Psychiat­­ry Med 2011; 41: 15–28.

18. Eyre H, Baune BT. Neuroimmunological effects of physical exercise in depression. Brain Behav Immun 2012; 26: 251–266.

19. Sciolino NR, Holmes PV. Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms. Neurosci Biobehav Rev 2012; 36: 1965–1984.

20. Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261–265.

21. Erickson KI, Miller DL, Roecklein KA. The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist 2012; 18: 82–97.

22. Schmolesky MT, Webb DL, Hansen RA. The effects of aerobic exercise intensity and duration on levels of brain-derived neurotrophic factor in healthy men. J Sports Sci Med 2013; 12: 502–511.

23. Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 2008; 22: 15–26.

24. Knaepen K, Goekint M, Heyman EM et al. Neuroplasticity – exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med 2010; 40: 765–801.

25. Scott KM, Bruffaerts R, Tsang A et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord 2007; 103: 113–120.

26. Roest AM, Martens EJ, de Jonge P et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010; 56: 38–46.

27. Smolík P, Zvolský P. Duševní a behaviorální poruchy: průvodce klasifikací, nástin nozologie, diagnostika. Praha: Maxdorf 1996.

28. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosom Med 1995; 57: 582–591.

29. Pedersen SS, Denollet J. Is type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Current Cardiology Reviews 2006; 2: 205.

30. O‘Dell KR, Masters KS, Spielmans GI et al. Does type-D personality predict outcomes among patients with cardiovascular disease? A meta-analytic review. J Psychosom Res 2011; 71: 199–206.

31. Denollet J, de Jonge P, Kuyper A et al. Depression and Type D personality represent different forms of distress in the myocardial infarction and depression – intervention trial (MIND-IT). Psychol Med 2009; 39: 749–756.

32. Grande G, Romppel M, Barth J. Association between type D personality and prognosis in patients with cardiovascular diseases: a systematic review and meta-analysis. Ann Behav Med 2012; 43: 299–310.

33. Raboch J, Psychiatrická společnost ČLS JEP. Psychiatrie: doporučené postupy psychiatrické péče III. V Tribunu EU vyd. 2. ed. Brno: Tribun EU 2010.